Ken H Baxa, DO | |
252 W 9th St Ste A, Hoisington, KS 67544-1700 | |
(620) 653-2386 | |
(620) 653-4186 |
Full Name | Ken H Baxa |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 10 Years |
Location | 252 W 9th St Ste A, Hoisington, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386020741 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Republic County Hospital | Belleville, KS | Hospital |
Ellsworth County Medical Center | Ellsworth, KS | Hospital |
Clara Barton Hospital | Hoisington, KS | Hospital |
Lindsborg Community Hospital | Lindsborg, KS | Hospital |
St Luke Hospital & Living Center | Marion, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ellsworth County Medical Center | 5395643357 | 13 |
Great Plains Of Republic Co Inc | 0446211684 | 4 |
Lindsborg Community Hospital Association | 3971556580 | 19 |
The Clara Barton Hospital Association Inc Hoisington Kansas | 6709798622 | 26 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | The Clara Barton Hospital Association Inc Hoisington Kansas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114964111 PECOS PAC ID: 6709798622 Enrollment ID: O20040120001002 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Ellsworth County Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972504546 PECOS PAC ID: 5395643357 Enrollment ID: O20040716000216 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Great Plains Of Republic Co Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932122215 PECOS PAC ID: 0446211684 Enrollment ID: O20041021000602 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Lindsborg Community Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023001021 PECOS PAC ID: 3971556580 Enrollment ID: O20050223000687 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Hospital District No 1 Marion Co |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144355793 PECOS PAC ID: 7517923196 Enrollment ID: O20050428000824 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Hospital District No 1 Marion Co |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1326087966 PECOS PAC ID: 7517923196 Enrollment ID: O20061104000413 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Entity Name | Great Plains Of Republic Co Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1396765145 PECOS PAC ID: 0446211684 Enrollment ID: O20061104000710 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Ken H Baxa, DO 252 W 9th St, Hoisington, KS 67544-1725 Ph: (620) 653-2386 | Ken H Baxa, DO 252 W 9th St Ste A, Hoisington, KS 67544-1700 Ph: (620) 653-2386 |
News Archive
In his laboratory in the National Human Genome Research Institute in Bethesda, Md., Paul Liu, M.D., Ph.D., is working on targeted treatments for leukemia, a life-threatening blood cancer.
Loss or impairment of the ability to speak is one of the most feared complications of stroke-one faced by about 20% of stroke patients. Language, as one of the most complex functions of the brain, is not seated in a single brain region but involves connections between many regions.
Many college students are making their way back to campus this month, and back to the habits - good or bad - that dorm-life promotes. A new study finds that young adults under 25, including high school grads and college students, are more likely to rate hookah and e-cigarettes as safer than cigarettes, when compared to 25 to 34-year-olds.
Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study presented by Susan M. Domchek, MD, executive director of the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, at the American Society of Clinical Oncology Annual Meeting.
› Verified 6 days ago
Nathaniel C Knackstedt, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 252 W 9th St Ste A, Hoisington, KS 67544 Phone: 620-653-2386 Fax: 620-653-4186 |